Product Recalls: April 17, 2024 – May 15, 2024
Health Letter, June 2024
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS II
clorazepate dipotassium tablets, 3.75 or 7.5 mg, 100 or 500 tablets per bottle. Distributed by Aurobindo Pharma USA, Inc. Lot #: CZA124001B, CZA124002B or CZA124003B, exp. date: 12/31/2025; Lot #: CZA124001A or CZA124003A, exp. date: 12/31/2025; Lot #: CZB124001B, CZB124002B or CZB124003B, exp. date: 12/31/2025; Lot #: CZB124001A or CZB124003A, exp. date: 12/31/2025.
diltiazem hydrochloride extended-release capsules, 120 mg, twice-a-day dosage, 100 capsules per bottle. Manufactured for: Glenmark Pharmaceuticals Inc. Lot #: 17221312, exp. date: 5/31/2024.
duloxetine delayed-release capsules; 20, 30 or 60 mg; 90-, 500- or 1,000-count bottles. Manufactured by: Towa Pharmaceutical Europe. Lot #: 220265, exp. date: Feb 2025; Lot #: 220088, exp. date: Nov 2024; Lot #: 220267, exp. date: Feb 2025; Lot #: 220256, exp. date: Feb 2025; Lot #: 220225, exp. date: Jan 2025; Lot #: 220269, exp. date: Feb 2025; Lot #: 220456, exp. date: Feb 2025; Lot #: 230028C, exp. date: Nov 2025; Lot #: 230106C, exp. date: Dec 2025; Lot #: 230170C, exp. date: Dec 2025; Lot #: 220039, exp. date: Dec 2024; Lot #: 220363, exp. date: Feb 2025.
methylergonovine maleate tablets, 0.2 mg, 12-count bottle. Distributed by: Amneal Pharmaceuticals, LLC. Lot #: BJ01922A, exp. date 03/2024.
Minolira (minocycline hydrochloride) extended-release tablets, 105 or 135 mg, 30-count bottle. Manufactured by: Dr Reddy’s Laboratories Limited. Lot #: T2300765, exp. date: 11/30/2025; Lot #: T2201702A, exp. date: 02/28/2025; Lot #: T2201699, exp. date: 2/28/2025; Lot #: T2201698, exp. date: 2/28/2025; Lot #: T2201700, exp. date: 02/28/2025; Lot #: T2201701, exp. date: 02/28/2025.
tramadol hydrochloride tablets, 50 mg, 1,000-count bottle. Distributed by: Advagen Pharma Limited. Manufactured by: Rubicon Research, Private Limited. Lot #: 230774Hl, exp. date: 4/30/2026.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.